Cargando…
MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2
Clinical application of doxorubicin (DOX), an anthracycline antibiotic with potent anti- tumor effects, is limited because of its cardiotoxicity. However, its pathogenesis is still not entirely understood. The aim of this paper was to explore the mechanisms and new drug targets to treat DOX-induced...
Autores principales: | Zhao, Lisha, Qi, Yan, Xu, Lina, Tao, Xufeng, Han, Xu, Yin, Lianhong, Peng, Jinyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975069/ https://www.ncbi.nlm.nih.gov/pubmed/29304479 http://dx.doi.org/10.1016/j.redox.2017.12.013 |
Ejemplares similares
-
Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress
por: Zhao, Lisha, et al.
Publicado: (2018) -
MicroRNA-140-5p aggravates hypertension and oxidative stress of atherosclerosis via targeting Nrf2 and Sirt2
por: Liu, Qing-Quan, et al.
Publicado: (2019) -
MicroRNA-874-3p Aggravates Doxorubicin-Induced Renal Podocyte Injury via Targeting Methionine Sulfoxide Reductase B3
por: Dai, Yan, et al.
Publicado: (2020) -
Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway
por: Lu, Guangping, et al.
Publicado: (2022) -
Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
por: Zhao, Xiaopeng, et al.
Publicado: (2023)